Childhood neuroblastoma treatment enhanced with high blood pressure ‘beta-blockers’ Posted on May 29, 2013February 25, 2018 by Carly du Toit An ‘old’ drug which is normally used to treat high blood pressure in adults could bring new hope to children with Neuroblastoma, researchers from the Children’s Cancer Institute Australia have discovered. Neuroblastoma is a cancer that develops from nerve cells left over from a baby’s development in the womb, predominantly affecting very young children – between 0 and 5 years old. But researchers conducting pre-clinical trials at CCIA (a world-class facility that the ACRF is proud to have funded via a $3.1m grant) have combined standard chemotherapy with beta-blockers to successfully enhance the effectiveness of the chemotherapy – paving the way towards better treatment outcomes, and decreased treatment doses for these young children. Their study has been published in the prestigious British Journal of Cancer. Continue reading “Childhood neuroblastoma treatment enhanced with high blood pressure ‘beta-blockers’”
